In traditional oncology treatment, drugs are administered systemically through the bloodstream, often missing the targeted tumor and causing severe side effects in vital organs.
OncoLize offers a different approach by directly injecting drug depots into tumors, concentrating the medication where it's needed most. This targeted delivery method increases treatment efficacy, reduces side effects, and lowers overall costs. By delivering high drug concentrations to the tumor site, OncoLize minimizes exposure to healthy tissues. This innovative strategy enhances tumor eradication potential while sparing the rest of the body.
Use the form below to register your interest in participating in future clinical trials or to receive updates about OncoLize, including our latest research, clinical progress, and company developments.

Direct Drug Delivery In Difficult-to-Treat Solid Tumors
